| scholarly article | Q13442814 |
| P50 | author | Michael John Gill | Q56334589 |
| P2093 | author name string | Hartmut B Krentz | |
| P2860 | cites work | Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model | Q29305377 |
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Reduction in hospitalization costs, morbidity, disability, and mortality in patients with aids treated with protease inhibitors | Q33181640 | ||
| A systematic review of task- shifting for HIV treatment and care in Africa | Q33548102 | ||
| The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for Europe | Q33551423 | ||
| Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? | Q33956969 | ||
| Cost effectiveness of combination HIV therapy: 3 years later | Q34007161 | ||
| Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
| The cost of HIV treatment and care. A global review | Q34185255 | ||
| The economic burden of late entry into medical care for patients with HIV infection | Q34497355 | ||
| The direct costs of HIV/AIDS care | Q34497622 | ||
| The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic | Q34554572 | ||
| Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings | Q34567572 | ||
| Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa | Q34831668 | ||
| The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection | Q35019915 | ||
| The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001. | Q35152268 | ||
| Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies | Q36285986 | ||
| Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing | Q36916579 | ||
| Late diagnosis of HIV in Europe: definitional and public health challenges | Q37334197 | ||
| Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis | Q37452644 | ||
| The economic impact of AIDS in the United States | Q39628234 | ||
| Indirect costs of HIV/AIDS mortality in Canada | Q41018024 | ||
| Forecasts of the costs of medical care for persons with HIV: 1992-1995. | Q41133747 | ||
| Average annual drug cost and its determinants in a population based cohort of HIV-positive adult men and women | Q42598223 | ||
| Distribution of health care expenditures for HIV-infected patients | Q42699465 | ||
| The lifetime cost of treating a person with HIV. | Q43838666 | ||
| The cost-effectiveness of preventing AIDS-related opportunistic infections | Q44294566 | ||
| Association of antiretroviral therapy adherence and health care costs | Q44400044 | ||
| Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. | Q45504898 | ||
| Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy | Q46276400 | ||
| Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy | Q46624490 | ||
| Indirect cost of HIV infection in England. | Q50668566 | ||
| Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. | Q50712911 | ||
| Impact of expanded HIV screening. | Q50954137 | ||
| Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 μl. | Q51152303 | ||
| The cost effectiveness of combination antiretroviral therapy for HIV disease. | Q52067020 | ||
| Estimating duration of HIV infection with CD4 cell count and HIV-1 RNA at presentation | Q56342162 | ||
| Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study | Q56539634 | ||
| The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004) | Q57181102 | ||
| Assessing the cost-effectiveness of HAART for adults with HIV in England | Q57181353 | ||
| Interferon for Melanoma: Another Application of Immunopharmacology | Q57259810 | ||
| The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection | Q57832358 | ||
| Survival Benefit of Initiating Antiretroviral Therapy in HIV-Infected Persons in Different CD4+ Cell Strata | Q73267062 | ||
| Long-term impact of highly active antiretroviral therapy on HIV-related health care costs | Q74015464 | ||
| The costs of triple-drug anti-HIV therapy for adults in the Americas | Q74493790 | ||
| Costs of HIV medical care in the era of highly active antiretroviral therapy | Q77889196 | ||
| The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001 | Q81205100 | ||
| "Test and treat": is it enough? | Q83514910 | ||
| Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence | Q94149823 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 757135 | |
| P577 | publication date | 2011-08-29 | |
| P1433 | published in | AIDS Research and Treatment | Q26854014 |
| P1476 | title | The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period | |
| P478 | volume | 2012 |
| Q35993151 | Advanced HIV disease at presentation to care in Nairobi, Kenya: late diagnosis or delayed linkage to care?--a cross-sectional study |
| Q37077894 | Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines. |
| Q30420558 | Controlling the HIV/AIDS epidemic: current status and global challenges |
| Q38646158 | Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis |
| Q28483957 | Early identification of HIV: empirical support for jail-based screening |
| Q36726127 | Economic and health implications from earlier detection of HIV infection in the United Kingdom |
| Q42287622 | Economic burden of late presentation in HIV disease in Austria: a comparison of the initial costs imposed by advanced HIV disease vs. non-late presentation |
| Q42286859 | Effect of late HIV diagnosis on HIV-related mortality among adults in general hospitals of Central Zone Tigray, northern Ethiopia: a retrospective cohort study |
| Q47116663 | Evaluation of the Utility of Point-of-Care HIV Testing on a Canadian Internal Medicine Inpatient Unit |
| Q34275769 | Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in India |
| Q36777532 | Feasibility and success of HIV point-of-care testing in an emergency department in an urban Canadian setting |
| Q91734897 | Feasibility of community-based HIV self-screening in South Africa: a demonstration project |
| Q26786152 | Gender difference in advanced HIV disease and late presentation according to European consensus definitions |
| Q91650265 | Increasing the Offer, Shifting the Offer: Patients' Perspectives on Routinely Offering HIV Counseling and POC Testing in the Health Services Program of an Urban Community Health Centre |
| Q41534211 | Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort |
| Q37701098 | Late HIV diagnosis: Differences by rural/urban residence, Florida, 2007-2011. |
| Q64069118 | Late Onset of Antiretroviral Therapy in Adults Living with HIV in an Urban Area in Brazil: Prevalence and Risk Factors |
| Q54254118 | Late Presentation of HIV Infection in the Netherlands: Reasons for Late Diagnoses and Impact on Vocational Functioning. |
| Q35734979 | Missed opportunities for HIV screening in pharmacies and retail clinics. |
| Q64067449 | Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study |
| Q35953907 | Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study |
| Q39658320 | Prior history of testing for syphilis, hepatitis B and hepatitis C among a population-based cohort of HIV-positive individuals and their HIV-negative controls. |
| Q36300125 | Psychosocial determinants of HIV testing across stages of change in Spanish population: a cross-sectional national survey |
| Q35368446 | Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study |
| Q38892405 | Rewriting the narrative of the epidemiology of HIV in sub-Saharan Africa |
| Q36125238 | Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study |
| Q35462359 | Testing initiatives increase rates of HIV diagnosis in primary care and community settings: an observational single-centre cohort study |
| Q36187833 | The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population. |
| Q35915467 | The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries |
| Q28535577 | The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients |
| Q34441451 | Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study |
Search more.